Clinical manifestations and treatment of Anderson-Fabry disease in a middle age man (RCD code: III-2B.2a)

Journal Title: Journal of Rare Cardiovascular Diseases - Year 2014, Vol 2, Issue 1

Abstract

Fabry disease is a genetic lysosomal storage disease (X-linked inheritance), also known as Anderson Fabry disease. It is a lifelong progressive disease, and it develops in patients with the lack of lysosomal enzyme alpha-galactosidase (a-Gal A) and for that reason the globotriaosylceramide(GL-3) accumulates in the endothelium of blood vessels and internal organs, then injury of various organ systems occurs, as renal insufficiency, gastrointestinal disorders, specific changes of the eye fundus, injury of the coronary arteries, hypertrophy of the left ventricle, cardiomyopathy, disorders of the nervous system, specific skin rashes (known as angioceratoma), etc. Therefore, patients with Fabry disease may occur in the practice of each speciality physician. A minor disease course, that occurs in older patients, mainly affects the cardiovascular system and may be undiagnosed. JRCD 2014; 2 (1): 15–17

Authors and Affiliations

Jurgita Plisiene, Rūta Marija Babarskienė, Dovilė Šeikytė, Eglė Ereminienė, Rokas Ereminas

Keywords

Related Articles

“One of the greatest disease is to be nobody to anybody”

Saint Mother Teresa of CalcuttaDear Readers,Before we go any further, try to ponder the quote once said by the Saint Teresa of Calcutta. She was by far one of the most entitled person in the world to say such an unpleasa...

Pregnancy and congenital complete atrioventricular block: management during pregnancy and the periparturient period

Complete atrioventricular block (AVB) is rare during pregnancy. Congenital atrioventricular block is the most common type of heart block in this group of patients. About one‐third of female patients with complete AVB re...

Overlap cardiomyopathy – coexistence of hypertrophic and restrictive cardiomyopathy phenotypes in one patient (RCD code: III-2A.1)

Recent data indicate that substantial proportion of cardiomyopathy patients have in fact more than one phenotype, the phenomenon termed as overlap or mixed cardiomyopathy. The molecular mechanisms and pathology as well a...

Prognostic value of inflammatory markers in acute coronary syndrome in a population with premature cardiovascular disease

Introduction: Inflammation plays a significant role in the development of atherosclerosis, and inflammatory markers could be used in risk assessment of patients with ischaemic heart disease. The use of such markers could...

Download PDF file
  • EP ID EP245448
  • DOI 10.20418/jrcd.vol2no1.162
  • Views 90
  • Downloads 0

How To Cite

Jurgita Plisiene, Rūta Marija Babarskienė, Dovilė Šeikytė, Eglė Ereminienė, Rokas Ereminas (2014). Clinical manifestations and treatment of Anderson-Fabry disease in a middle age man (RCD code: III-2B.2a). Journal of Rare Cardiovascular Diseases, 2(1), 15-17. https://europub.co.uk/articles/-A-245448